J. Goldman & CO LP Revolution Medicines, Inc. Transaction History
J. Goldman & CO LP
- $3.53 Billion
- Q4 2024
A detailed history of J. Goldman & CO LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 26,335 shares of RVMD stock, worth $1.09 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
26,335Holding current value
$1.09 Million% of portfolio
0.03%Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
299Shares Held
179MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$707 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$554 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$548 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$447 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$392 Million0.22% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.63B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...